Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver Fibrosis
Open accessAbstract
Direct induction of induced hepatocytes (iHeps) from fibroblasts holds potential as a strategy for regenerative medicine but until now has only been shown in culture settings. Here, we describe in vivo iHep formation using transcription factor induction and genetic fate tracing in mouse models of chronic liver disease. We show that ectopic expression of the transcription factors FOXA3, GATA4, HNF1A, and HNF4A from a polycistronic lentiviral vector converts mouse myofibroblasts into cells with a hepatocyte phenotype. In vivo expression of the same set of transcription factors from a p75 neurotrophin receptor peptide (p75NTRp)-tagged adenovirus enabled the generation of hepatocyte-like cells from myofibroblasts in fibrotic mouse livers and reduced liver fibrosis. We have therefore been able to convert pro-fibrogenic myofibroblasts in the liver into hepatocyte-like cells with positive functional benefits. This direct in vivo reprogramming approach may open new avenues for the treatment of chronic liver disease.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Liver transcription factor overexpression can reprogram fibroblasts into more mature hepatocytes.
“Recent progress has shown that liver transcription factor overexpression can reprogram fibroblasts into more mature hepatocytes (Huang et al., 2014; Sekiya and Suzuki, 2011; Song et al., 2016; Yu et al., 2013; Zhu et al., 2014).”
From A Roadmap for Human Liver Differentiation from Pluripotent Stem Cells (2018) · cites this paper as Song et al., 2016
Increased glycolysis has been implicated in experimental lung, liver, and kidney fibrosis models, and inhibition of glycolysis reduces extracellular matrix accumulation.
“Increased glycolysis has been implicated in experimental lung, liver and kidney fibrosis models and inhibition of glycolysis reduces ECM accumulation50–52.”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [51]
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673 · see citing works
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221 · see citing works
A global double-fluorescent Cre reporter mouse
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L., & Luo, L. (2007) · genesis · doi:10.1002/dvg.20335 · Cited by 3,491 · see citing works
Direct conversion of fibroblasts to functional neurons by defined factors
Vierbuchen, T., Ostermeier, A., Pang, Z. P., Kokubu, Y., Südhof, T. C., & Wernig, M. (2010) · Nature · doi:10.1038/nature08797 · Cited by 3,017 · see citing works
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors
Ieda, M., Fu, J.-D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B. G., & Srivastava, D. (2010) · Cell · doi:10.1016/j.cell.2010.07.002 · Cited by 2,454 · see citing works
Mederacke, I., Hsu, C. C., Troeger, J. S., Huebener, P., Mu, X., Dapito, D. H., Pradere, J.-P., & Schwabe, R. F. (2013) · Nature Communications · doi:10.1038/ncomms3823 · Cited by 1,443 · see citing works
Self-citationIn vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Li, Q., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,353 · see citing works
Heart repair by reprogramming non-myocytes with cardiac transcription factors
Song, K., Nam, Y., Luo, X., Qi, X., Tan, W. H., Huang, G. N., Acharya, A., Smith, C. L., Tallquist, M. D., Neilson, E. G., et al. (2012) · Nature · doi:10.1038/nature11139 · Cited by 1,141 · see citing works
Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors
Huang, P., He, Z., Ji, S., Sun, H., Xiang, D., Liu, C., Hu, Y., Wang, X., & Hui, L. (2011) · Nature · doi:10.1038/nature10116 · Cited by 864 · see citing works
Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors
Sekiya, S., & Suzuki, A. (2011) · Nature · doi:10.1038/nature10263 · Cited by 846 · see citing works
Guo, Z., Zhang, L., Wu, Z., Chen, Y., Wang, F., & Chen, G. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.12.001 · Cited by 829 · see citing works
Therapy for Fibrotic Diseases: Nearing the Starting Line
Friedman, S. L., Sheppard, D., Duffield, J. S., & Violette, S. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004700 · Cited by 655 · see citing works
Conversion of Mouse and Human Fibroblasts into Functional Spinal Motor Neurons
Son, E., Ichida, J. K., Wainger, B. J., Toma, J. S., Rafuse, V. F., Woolf, C. J., & Eggan, K. C. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.07.014 · Cited by 629 · see citing works
Direct reprogramming of mouse fibroblasts to neural progenitors
Kim, J., Efe, J. A., Zhu, S., Talantova, M. V., Xu, Y., Wang, S., Lipton, S. A., Zhang, K., & Ding, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103113108 · Cited by 568 · see citing works
Direct Reprogramming of Human Fibroblasts to Functional and Expandable Hepatocytes
Huang, P., Zhang, L., Gao, Y., He, Z., Yao, D., Wu, Z., Cen, J., Chen, X., Liu, C., Hu, Y., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.01.003 · Cited by 560 · see citing works
Ring, K. L., Tong, L. M., Balestra, M. E., Javier, R., Andrews-Zwilling, Y. S., Li, G., Walker, D., Zhang, W. R., Kreitzer, A. C., & Huang, Y. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.05.018 · Cited by 540 · see citing works
CellNet: Network Biology Applied to Stem Cell Engineering
Cahan, P., Li, H., Morris, S. A., da Rocha, E. L., Daley, G. Q., & Collins, J. J. (2014) · Cell · doi:10.1016/j.cell.2014.07.020 · Cited by 522 · see citing works
Direct Reprogramming of Fibroblasts into Neural Stem Cells by Defined Factors
Han, D., Tàpia, N., Hermann, A., Hemmer, K., Höing, S., Araúzo-Bravo, M. J., Zaehres, H., Wu, G., Frank, S., Moritz, S., et al. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.02.021 · Cited by 514 · see citing works
Self-citationDirect Conversion of Fibroblasts into Stably Expandable Neural Stem Cells
Thier, M. C., Wörsdörfer, P., Lakes, Y. B., Gorris, R., Herms, S., Opitz, T., Seiferling, D., Quandel, T., Hoffmann, P., Nöthen, M. M., et al. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.03.003 · Cited by 485 · see citing works
Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration
Malato, Y., Naqvi, S., Schürmann, N., Ng, R., Wang, B., Zape, J., Kay, M. A., Grimm, D., & Willenbring, H. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59261 · Cited by 434 · see citing works
Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells
Lujan, E., Chanda, S., Ahlenius, H., Südhof, T. C., & Wernig, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121003109 · Cited by 421 · see citing works
In vivo conversion of astrocytes to neurons in the injured adult spinal cord
Su, Z., Niu, W., Liu, M.-L., Zou, Y., & Zhang, C. (2014) · Nature Communications · doi:10.1038/ncomms4338 · Cited by 413 · see citing works
Generation of induced neurons via direct conversion in vivo
Torper, O., Pfisterer, U., Wolf, D. A., Pereira, M., Lau, S., Jakobsson, J., Björklund, A., Grealish, S., & Parmar, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303829110 · Cited by 412 · see citing works
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming
Du, Y., Wang, J., Jia, J., Song, N., Xiang, C., Xu, J., Hou, Z., Su, X., Liu, B., Jiang, T., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.01.008 · Cited by 320 · see citing works
Dissecting Engineered Cell Types and Enhancing Cell Fate Conversion via CellNet
Morris, S. A., Cahan, P., Li, H., Zhao, A., Roman, A. K. S., Shivdasani, R. A., Collins, J. J., & Daley, G. Q. (2014) · Cell · doi:10.1016/j.cell.2014.07.021 · Cited by 267 · see citing works
Environmental impact on direct neuronal reprogramming in vivo in the adult brain
Grande, A. W., Sumiyoshi, K., López‐Juárez, A., Howard, J., Sakthivel, B., Aronow, B. J., Campbell, K., & Nakafuku, M. (2013) · Nature Communications · doi:10.1038/ncomms3373 · Cited by 225 · see citing works
Schambach, A., Mueller, D., Galla, M., Verstegen, M. M. A., Wagemaker, G., Loew, R., Baum, C., & Bohne, J. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302807 · Cited by 143 · see citing works
Self-citationPuche, J. E., Lee, Y. A., Jiao, J., Aloman, C., Fiel, M. I., Muñoz, U., Kraus, T., Lee, T., Yee, H. F., & Friedman, S. L. (2013) · Hepatology · doi:10.1002/hep.26053 · Cited by 136 · see citing works
Resetting the transcription factor network reverses terminal chronic hepatic failure
Nishikawa, T., Bell, A., Brooks, J. M., Setoyama, K., Melis, M., Han, B., Fukumitsu, K., Handa, K., Tian, J., Kaestner, K. H., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73137 · Cited by 124 · see citing works
Kendall, T. J., Hennedige, S., Aucott, R. L., Hartland, S. N., Vernon, M. A., Benyon, R. C., & Iredale, J. P. (2008) · Hepatology · doi:10.1002/hep.22701 · Cited by 119 · see citing works
MicroRNA-221 regulates FAS-induced fulminant liver failure
Sharma, A. D., Narain, N., Händel, E.-M., Iken, M., Singhal, N., Cathomen, T., Manns, M. P., Schöler, H. R., Ott, M., & Cantz, T. (2011) · Hepatology · doi:10.1002/hep.24243 · Cited by 76 · see citing works
Self-citationPolyclonal fluctuation of lentiviral vector–transduced and expanded murine hematopoietic stem cells
Maetzig, T., Brugman, M. H., Bartels, S., Heinz, N., Kustikova, O. S., Modlich, U., Li, Z., Galla, M., Schiedlmeier, B., Schambach, A., et al. (2011) · Blood · doi:10.1182/blood-2010-08-303222 · Cited by 55 · see citing works
Self-citationDevelopment of Adenoviral Delivery Systems to Target Hepatic Stellate Cells In Vivo
Reetz, J., Genz, B., Meier, C., Kowtharapu, B. S., Timm, F., Vollmar, B., Herchenröder, O., Abshagen, K., & Pützer, B. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067091 · Cited by 37 · see citing works
Self-citationIacob, R. A., Rüdrich, U., Rothe, M., Kirsch, S., Maasoumy, B., Narain, N., Verfaillie, C. M., Sancho‐Bru, P., Iken, M., Popescu, I., et al. (2011) · Stem Cell Research · doi:10.1016/j.scr.2011.02.002 · Cited by 32 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868 · see citing works
Hepatic stellate cells as key target in liver fibrosis
Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485 · see citing works
Humphreys, B. D. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034227 · Cited by 1,239 · see citing works
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Parola, M., & Pinzani, M. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.09.002 · Cited by 1,183 · see citing works
Fibroblasts: Origins, definitions, and functions in health and disease
Plikus, M. V., Wang, X., Sinha, S., Forte, E., Thompson, S. M., Herzog, E. L., Driskell, R. R., Rosenthal, N. A., Biernaskie, J. A., & Horsley, V. (2021) · Cell · doi:10.1016/j.cell.2021.06.024 · Cited by 1,162 · see citing works
Wound healing, fibroblast heterogeneity, and fibrosis
Talbott, H. E., Mascharak, S., Griffin, M., Wan, D. C., & Longaker, M. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.07.006 · Cited by 745 · see citing works
Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications
Liu, G., David, B. T., Trawczynski, M., & Fessler, R. G. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09935-x · Cited by 527 · see citing works
Direct cell reprogramming: approaches, mechanisms and progress
Wang, H., Yang, Y., Liu, J., & Li, Q. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00335-z · Cited by 438 · see citing works
Jun, J.-I., & Lau, L. F. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93563 · Cited by 348 · see citing works
Chen, Y., Ma, N., Pei, Z.-F., Wu, Z., Monte, F. H. D., Keefe, S. H., Yellin, E., Chen, M. S., Yin, J.-C., Lee, G., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.09.003 · Cited by 316 · see citing works
In Vivo Cellular Reprogramming: The Next Generation
Srivastava, D., & DeWitt, N. (2016) · Cell · doi:10.1016/j.cell.2016.08.055 · Cited by 292 · see citing works
Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression
Caligiuri, A., Gentilini, A., Pastore, M., Gitto, S., & Marra, F. (2021) · Cells · doi:10.3390/cells10102759 · Cited by 273 · see citing works
A Roadmap for Human Liver Differentiation from Pluripotent Stem Cells
Ang, L. T., Tan, A. K. Y., Autio, M. I., Goh, S. H., Choo, S. H., Lee, K. L., Tan, J., Pan, B., Lee, J. J. H., Lum, J. J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.087 · Cited by 220 · see citing works
“Recent progress has shown that liver transcription factor overexpression can reprogram fibroblasts into more mature hepatocytes (Huang et al., 2014; Sekiya and Suzuki, 2011; Song et al., 2016; Yu et al., 2013; Zhu et al., 2014).”
BackgroundIn Vivo Reprogramming for CNS Repair: Regenerating Neurons from Endogenous Glial Cells
Li, H., & Chen, G. (2016) · Neuron · doi:10.1016/j.neuron.2016.08.004 · Cited by 174 · see citing works
Géraud, C., Reiners-Koch, P.-S., Zierow, J., Klapproth, K., Busch, K., Olsavszky, V., Leibing, T., Demory, A., Ulbrich, F., Diett, M., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90086 · Cited by 163 · see citing works
Walters, B. J., Coak, E., Dearman, J., Bailey, G. F., Yamashita, T., Kuo, B., & Zuo, J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.044 · Cited by 145 · see citing works
Yang, A.-T., Kim, Y.-O., Yan, X.-Z., Abe, H., Aslam, M., Park, K.-S., Zhao, X.-Y., Jia, J.-D., Klein, T., You, H., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.12.005 · Cited by 144 · see citing works
Xiang, D., Cheng, Z., Liu, H., Wang, X. B., Han, T., Sun, W. C., Li, X., Yang, W., Chen, C. Y., Xia, M., et al. (2016) · Hepatology · doi:10.1002/hep.28919 · Cited by 142 · see citing works
Epithelial Plasticity during Liver Injury and Regeneration
Gadd, V. L., Aleksieva, N., & Forbes, S. J. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.08.016 · Cited by 142 · see citing works
Chen, Y., Gu, Y., Li, Y., Li, G., Chai, R., Li, W., & Li, H. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109016 · Cited by 104 · see citing works
Reprogramming cell fates by small molecules
Ma, X., Kong, L., & Zhu, S. (2017) · Protein & Cell · doi:10.1007/s13238-016-0362-6 · Cited by 98 · see citing works
The clinical manifestations and molecular pathogenesis of radiation fibrosis
Fijardo, M., Kwan, J. Y. Y., Bissey, P.-A., Citrin, D. E., Yip, K. W., & Liu, F. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105089 · Cited by 93 · see citing works
Fibroblast activation and heterogeneity in fibrotic disease
Zhang, X., Zhang, Y., & Liu, Y. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-025-00969-8 · Cited by 77 · see citing works
Advances in cancer stem cell targeting: How to strike the evil at its root
Pützer, B. M., Solanki, M., & Herchenröder, O. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.013 · Cited by 73 · see citing works
Self-citationMolecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis
Wang, F.-D., Zhou, J., & Chen, E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.787748 · Cited by 74 · see citing works
Liver cell therapy: is this the end of the beginning?
Alwahsh, S. M., Rashidi, H., & Hay, D. C. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2713-8 · Cited by 70 · see citing works
Down-regulation of Beclin1 promotes direct cardiac reprogramming
Wang, L., Ma, H., Huang, P., Xie, Y., Near, D., Wang, H., Xu, J., Yang, Y., Xu, Y., Garbutt, T. A., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay7856 · Cited by 70 · see citing works
The Dynamics of Transcriptional Activation by Hepatic Reprogramming Factors
Horisawa, K., Udono, M., Ueno, K., Ohkawa, Y., Nagasaki, M., Sekiya, S., & Suzuki, A. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.07.012 · Cited by 68 · see citing works
Phenotypical and Functional Polymorphism of Liver Resident Macrophages
Elchaninov, A. V., Fatkhudinov, T., Vishnyakova, P., Lokhonina, А. V., & Sukhikh, G. T. (2019) · Cells · doi:10.3390/cells8091032 · Cited by 66 · see citing works
Engineering Liver Microtissues for Disease Modeling and Regenerative Medicine
Huang, D. (., Gibeley, S. B., Xu, C., Xiao, Y., Celik, O., Ginsberg, H. N., & Leong, K. W. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909553 · Cited by 65 · see citing works
Nakamori, D., Akamine, H., Takayama, K., Sakurai, F., & Mizuguchi, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-16856-7 · Cited by 64 · see citing works
Chan, Y.-T., Wang, N., Tan, H. Y., Li, S., & Feng, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00548 · Cited by 62 · see citing works
Engineering Biomaterials with Micro/Nanotechnologies for Cell Reprogramming
Fang, J., Hsueh, Y., Soto, J., Sun, W., Wang, J., Gu, Z., Khademhosseini, A., & Li, S. (2020) · ACS Nano · doi:10.1021/acsnano.9b04837 · Cited by 60 · see citing works
Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis
Guo, S. (2018) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12221 · Cited by 58 · see citing works
Gong, L., Wei, F., Gonzalez, F. J., & Li, G. (2023) · Hepatology · doi:10.1097/hep.0000000000000182 · Cited by 58 · see citing works
Cell Fate Reprogramming in the Era of Cancer Immunotherapy
Zimmermannova, O., Caiado, I., Ferreira, A. G., & Pereira, C.-F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.714822 · Cited by 56 · see citing works
Merkt, W., Zhou, Y., Han, H., & Lagares, D. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12952 · Cited by 56 · see citing works
Sgodda, M., Dai, Z., Zweigerdt, R., Sharma, A. D., Ott, M., & Cantz, T. (2017) · Stem Cells and Development · doi:10.1089/scd.2017.0023 · Cited by 53 · see citing works
Self-citationAntifibrotics in chronic liver disease: tractable targets and translational challenges
Ramachandran, P., & Henderson, N. C. (2016) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(16)30110-8 · Cited by 51 · see citing works
Christoforou, N., Chakraborty, S., Kirkton, R. D., Adler, A. F., Addis, R. C., & Leong, K. W. (2017) · Scientific Reports · doi:10.1038/srep40285 · Cited by 47 · see citing works
Assessment of engineered cells using CellNet and RNA-seq
Radley, A., Schwab, R. M., Tan, Y., Kim, J., Lo, E. K. W., & Cahan, P. (2017) · Nature Protocols · doi:10.1038/nprot.2017.022 · Cited by 44 · see citing works
Chin, A. F., Han, J., Clement, C. C., Choi, Y., Zhang, H., Browne, M., Jeon, O. H., & Elisseeff, J. H. (2023) · Aging Cell · doi:10.1111/acel.13979 · Cited by 49 · see citing works
Gene regulatory networks in differentiation and direct reprogramming of hepatic cells
Gérard, C., Tys, J., & Lemaigre, F. P. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.12.003 · Cited by 46 · see citing works
Khaw, P. T., Bouremel, Y., Brocchini, S., & Henein, C. (2020) · Eye · doi:10.1038/s41433-020-1031-9 · Cited by 46 · see citing works
Targeting secreted cytokine BMP9 gates the attenuation of hepatic fibrosis
Li, P., Li, Y., Zhu, L., Yang, Z. H., He, J., Wang, L., Shang, Q., Pan, H., Wang, H., Ma, X., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.12.008 · Cited by 46 · see citing works
Progress in stem cell‐based therapy for liver disease
Shiota, G., & Itaba, N. (2016) · Hepatology Research · doi:10.1111/hepr.12747 · Cited by 45 · see citing works
Guo, R., Tang, W., Yuan, Q., Hui, L., Wang, X., & Xie, X. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.06.013 · Cited by 45 · see citing works
Self-citationHepatic stellate cells: fibrogenic, regenerative or both? Heterogeneity and context are key
Bansal, M. B. (2016) · Hepatology International · doi:10.1007/s12072-016-9758-x · Cited by 42 · see citing works
Liu, J., Zhao, B., Zhu, H., Pan, Q., Cai, M., Bai, X., Li, X., Hu, X., Zhang, M., Shi, J., et al. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03110-x · Cited by 41 · see citing works
Krooss, S. A., Dai, Z., Schmidt, F., Rovai, A., Fakhiri, J., Dhingra, A., Yuan, Q., Yang, T., Balakrishnan, A., Steinbrück, L., et al. (2019) · iScience · doi:10.1016/j.isci.2019.100764 · Cited by 42 · see citing works
Self-citationTargeting HSP47 and HSP70: promising therapeutic approaches in liver fibrosis management
El-Fattah, E. E. A., & Zakaria, A. Y. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03759-z · Cited by 41 · see citing works
Antifibrotics in liver disease: are we getting closer to clinical use?
Bansal, M. B., & Chamroonkul, N. (2018) · Hepatology International · doi:10.1007/s12072-018-9897-3 · Cited by 40 · see citing works
Mathison, M. N., Singh, V., Sanagasetti, D., Yang, L., Pinnamaneni, J. P., Yang, J., & Rosengart, T. K. (2017) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2017.06.035 · Cited by 36 · see citing works
Wound healing and fibrosis: current stem cell therapies
Jones, R. E., Foster, D. S., Hu, M. S.-M., & Longaker, M. T. (2019) · Transfusion · doi:10.1111/trf.14836 · Cited by 36 · see citing works
Jain, N., Goyal, Y., Dunagin, M. C., Cote, C. J., Mellis, I. A., Emert, B. L., Jiang, C., Dardani, I. P., Reffsin, S., Arnett, M. J., et al. (2024) · Cell Systems · doi:10.1016/j.cels.2024.01.001 · Cited by 30 · see citing works
Takashima, Y., Horisawa, K., Udono, M., Ohkawa, Y., & Suzuki, A. (2018) · Cancer Science · doi:10.1111/cas.13798 · Cited by 35 · see citing works
Current Advances in Red Blood Cell Generation Using Stem Cells from Diverse Sources
Seo, Y., Shin, K., Kim, H. H., & Kim, H. (2019) · Stem Cells International · doi:10.1155/2019/9281329 · Cited by 35 · see citing works
Perivascular stromal cells: Directors of tissue immune niches
Sbierski‐Kind, J., Mroz, N. M., & Molofsky, A. B. (2021) · Immunological Reviews · doi:10.1111/imr.12984 · Cited by 33 · see citing works
In vivo reprogramming for tissue regeneration and organismal rejuvenation
Taguchi, J., & Yamada, Y. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.07.008 · Cited by 34 · see citing works
Chou, M.-J., Yu, H.-Y., Hsia, J.-C., Chen, Y., Hung, T.-T., Chao, H., Chern, E., & Huang, Y. (2018) · Materials · doi:10.3390/ma11020301 · Cited by 34 · see citing works
Park, S., Hwang, S. I., Kim, J., Hwang, S., Kang, S., Yang, S., Kim, J., Kang, W., Kim, K., Han, D., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1127-3 · Cited by 34 · see citing works
Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries
Horisawa, K., & Suzuki, A. (2020) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.96.012 · Cited by 34 · see citing works
Taniguchi, H., Fujimoto, A., Kono, H., Furuta, M., Fujita, M., & Nakagawa, H. (2018) · Oncotarget · doi:10.18632/oncotarget.25456 · Cited by 32 · see citing works
Design Approaches for Generating Organ Constructs
Xia, Y. F., & Belmonte, J. C. I. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.05.016 · Cited by 32 · see citing works
Space of Disse: a stem cell niche in the liver
Häussinger, D., & Kordes, C. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0283 · Cited by 32 · see citing works
New Technologies To Enhance In Vivo Reprogramming for Regenerative Medicine
Larouche, J. A., & Aguilar, C. A. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.11.003 · Cited by 28 · see citing works
GPC-3 in hepatocellular carcinoma; A novel biomarker and molecular target
Tehrani, H. A., Zangi, M., Fathi, M., Vakili, K. G., Hassan, M., Rismani, E., Hossein‐Khannazer, N., & Vosough, M. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114391 · Cited by 27 · see citing works
Direct reprogramming of somatic cells into induced hepatocytes: Cracking the Enigma code
Rombaut, M., Boeckmans, J., Rodrigues, R. M., van Grunsven, L. A., Vanhaecke, T., & Kock, J. D. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.04.048 · Cited by 26 · see citing works
Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders
Sofias, A. M., Lorenzi, F. D., Peña, Q., Shalmani, A. A., Vucur, M., Wang, J., Kiessling, F. M., Shi, Y., Consolino, L., Storm, G., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113831 · Cited by 27 · see citing works
Lan, Q., Ren, Z., Chen, Y., Cui, G., Choi, I. C., Ung, C. O. L., Yu, H. H., & Lee, S. M. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00434-1 · Cited by 25 · see citing works
Gene therapy approaches in the non-human primate model of Parkinson’s disease
Pignataro, D., Sucunza, D., Rico, A. J., Dopeso‐Reyes, I. G., Roda, E., Rodriguez-Perez, A. I., Labandeira-García, J. L., Broccoli, V., Kato, S., Kobayashi, K., et al. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1681-3 · Cited by 26 · see citing works
Strategies for in vivo reprogramming
Ofenbauer, A., & Tursun, B. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.06.002 · Cited by 25 · see citing works
The novel tool of cell reprogramming for applications in molecular medicine
Mall, M., & Wernig, M. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1550-4 · Cited by 24 · see citing works
Hepatic microenvironment underlies fibrosis in chronic hepatitis B patients
Yao, Q., Feng, Y., Han, P., Yang, F., & Song, G. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i27.3917 · Cited by 24 · see citing works
Self-citationCell and Tissue Therapy for the Treatment of Chronic Liver Disease
Bram, Y., Nguyen, D.-H. T., Gupta, V., Park, J., Richardson, C., Chandar, V., & Schwartz, R. E. (2021) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-112619-044026 · Cited by 24 · see citing works
Reprogramming the spleen into a functioning ‘liver’ in vivo
Liu, C., Wang, L., Xu, M., Sun, Y., Xing, Z., Zhang, J., Wang, C., & Dong, L. (2022) · Gut · doi:10.1136/gutjnl-2021-325018 · Cited by 25 · see citing works
Reprogramming cellular identity in vivo
Leaman, S., Marichal, N., & Berninger, B. (2022) · Development · doi:10.1242/dev.200433 · Cited by 22 · see citing works
Ma, H.-M., Zhang, Q., Yang, X., Hu, Y., Zhang, J., Chen, L., Zhao, B., Yang, W., & Xu, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8168988 · Cited by 22 · see citing works
Direct cellular reprogramming and inner ear regeneration
Atkinson, P. J., Kim, G. S., & Cheng, A. G.-L. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1564035 · Cited by 23 · see citing works
Liver stem cells: Plasticity of the liver epithelium
Tsuchiya, A., & Lu, W. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i9.1037 · Cited by 23 · see citing works
Chemically induced cell fate reprogramming and the acquisition of plasticity in somatic cells
Zhao, Y. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.04.025 · Cited by 20 · see citing works
Engineering kidney cells: reprogramming and directed differentiation to renal tissues
Kaminski, M. M., Tošić, J., Pichler, R., Arnold, S. J., & Lienkamp, S. S. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2629-5 · Cited by 20 · see citing works
Mitigation of liver fibrosis via hepatic stellate cells mitochondrial apoptosis induced by metformin
Su, Y., Lu, S., Hou, C., Ren, K., Wang, M., Liu, X., Zhao, S., & Liu, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108683 · Cited by 20 · see citing works
Alternative Cell Sources for Liver Parenchyma Repopulation: Where Do We Stand?
Tricot, T., De Boeck, J., & Verfaillie, C. (2020) · Cells · doi:10.3390/cells9030566 · Cited by 20 · see citing works
Innovation for hepatotoxicity in vitro research models: A review
Han, W., Wu, Q., Zhang, X., & Duan, Z. (2018) · Journal of Applied Toxicology · doi:10.1002/jat.3711 · Cited by 20 · see citing works
Li, C., Hsu, T., Chang, Y., Chan, M., Lu, P., & Hsiao, M. (2021) · Biomedicines · doi:10.3390/biomedicines9091265 · Cited by 19 · see citing works
Fibroblasts: New players in the central nervous system?
Duan, L., & Yu, X. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.01.014 · Cited by 19 · see citing works
Sokal-Dembowska, A., Jarmakiewicz-Czaja, S., Ferenc, K., & Filip, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105238 · Cited by 19 · see citing works
In Vitro Generated Hepatocyte-Like Cells: A Novel Tool in Regenerative Medicine and Drug Discovery.
Zakikhan, K., Pournasr, B., Massoud, V., & Marjan, N. A. (2017) · PubMed Central · doi:10.22074/cellj.2016.4362 · Cited by 19 · see citing works
In vivo reprogramming as a new approach to cardiac regenerative therapy
Sadahiro, T., & Ieda, M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.06.019 · Cited by 20 · see citing works
“The Good, the Bad, and the Ugly” – About Diverse Phenotypes of Hepatic Stellate Cells in the Liver
Bogomolova, A., Balakrishnan, A., Ott, M., & Sharma, A. D. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.01.002 · Cited by 18 · see citing works
Self-citationHoming in on the hepatic scar: recent advances in cell-specific targeting of liver fibrosis
Dobie, R., & Henderson, N. C. (2016) · F1000Research · doi:10.12688/f1000research.8822.1 · Cited by 18 · see citing works
Kim, S., Park, M. R., Choi, C., Kim, J. B., & Cha, C. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120688 · Cited by 18 · see citing works
Bench to bedside: Current advances in regenerative medicine
Clarke, G., Harley, P., Hubber, E.-L., Manea, T., Manuelli, L., Read, E., & Watt, F. M. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2018.05.006 · Cited by 18 · see citing works
Lim, B., Kamal, A., Gomez Ramos, B., Adrian Segarra, J. M., Ibarra, I. L., Dignas, L., Kindinger, T., Volz, K., Rahbari, M., Rahbari, N., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02081-w · Cited by 17 · see citing works
Emerging advancements in liver regeneration and organogenesis as tools for liver replacement
Huppert, S. S., & Campbell, K. M. (2016) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000365 · Cited by 17 · see citing works
Human Pluripotent Stem Cells: Myths and Future Realities for Liver Cell Therapy
Goldman, O., & Gouon–Evans, V. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.05.019 · Cited by 17 · see citing works
Liver fibrosis: Which mechanisms matter?
Weiskirchen, R., & Tacke, F. (2016) · Clinical Liver Disease · doi:10.1002/cld.581 · Cited by 17 · see citing works
Integrating Vectors for Gene Therapy and Clonal Tracking of Engineered Hematopoiesis
Biasco, L., Rothe, M., Schott, J. W., & Schambach, A. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.06.009 · Cited by 17 · see citing works
Self-citationSepporta, M.-V., Praz, V., Balmas Bourloud, K., Joseph, J.-M., Jauquier, N., Riggi, N., Nardou-Auderset, K., Petit, A., Scoazec, J.-Y., Sartelet, H., et al. (2022) · Communications Biology · doi:10.1038/s42003-021-02958-6 · Cited by 16 · see citing works
- Authors
- Song, G., Pacher, M., Balakrishnan, A., Yuan, Q., Tsay, H.-C., Yang, D., Reetz, J., Brandes, S., Dai, Z., Pützer, B. M., Araúzo-Bravo, M. J., Steinemann, D., Luedde, T., Schwabe, R. F., Manns, M. P., Schöler, H. R., Schambach, A., Cantz, T., Ott, M., & Sharma, A. D.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Universitätsmedizin Rostock (DE)
- Ikerbasque (ES)
- Universitätsklinikum Aachen (DE)
- Columbia University (US)
- Max Planck Institute for Molecular Biomedicine (DE)
- Corresponding author
- Ott, Michael
- Sharma, Amar Deep
- ORCID
- Venue
- Cell Stem Cell
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 18
- Issue
- 6
- Pages
- 797-808
- ISSN
- 1875-9777 (ISSN-L)
- 1934-5909
- OpenAlex
- W2278964323
- Cited by
- 208
- References
- 34
- Citations by year
- 2026: 4 · 2025: 16 · 2024: 17 · 2023: 12 · 2022: 18 · 2021: 26 · 2020: 19 · 2019: 21 · 2018: 25 · 2017: 31 · 2016: 19
- FWCI
- 23.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell stem cell (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (SFB-738, DFG SH640/1-2, DFG 188/9-1, DFG EXC 62/2)
- Bundesministerium für Bildung und Forschung
- China Scholarship Council
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- direct reprogramming, myofibroblasts, hepatocytes, liver fibrosis, transcription factors, FOXA3, GATA4, HNF1A, HNF4α, p75 neurotrophin receptor, adenoviral vector, lentiviral vectors, chronic liver disease, hepatocyte-like cells
- MeSH terms
- Dependovirus, Animals, Cholestasis, Dicarbethoxydihydrocollidine, Liver, Liver Cirrhosis, Mice, Inbred BALB C, Mice, Transgenic, Models, Biological, Transcription Factors, Biomarkers, Cell Lineage, Integrases, Oligonucleotide Array Sequence Analysis, Hepatocytes, Myofibroblasts, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review